- NLM Digital Collections - FDA oversightPublication: [Toronto, Ontario] : Thomson Reuters, 20-December-2021... Hodgkin lymphoma, including diffuse large B-cell lymphoma (DLBCL). Breyanzi is not indicated for the treatment of ... from promising concepts to practical cancer treatment regimens." DLBCL is the most common type of non-Hodgkin ...
4 results